Speeches and presentations
Search through our archive of speeches and presentations from conferences and events.
Visit our corporate reporting archive for our Annual Reports.
For quarterly results materials visit quarterly results.
30 November 2022
Evercore ISI HealthCONx Conference
Deborah Waterhouse, Chief Executive Officer of ViiV Healthcare, and Dr. Kimberly Smith, Head of R&D at ViiV Healthcare, discussed the progress being made in HIV innovation during a fireside chat at the Evercore ISI HealthCONx Conference Wednesday, November 30th, 1pm UK / 8:00am ET.
16 November 2022
Jefferies London Healthcare Conference
David Redfern, Chief Strategy Officer, participated in a fireside chat at the Jefferies London Healthcare Conference on Wednesday, 16 November 2022 at 09:45 GMT.
28 October 2022
Response to Investor Forum Letter
GSK’s response to an Investor Forum letter, regarding GSK’s redefined operating model post-Demerger.
21 October 2022
Investor science event: Getting ahead of respiratory syncytial virus in older adults
After presenting the positive AReSVi-006 pivotal phase III results for our RSV (respiratory syncytial virus) older adults vaccine candidate at IDWeek 2022, GSK management hosted an investor science event on 21 October 2022.
16 September 2022
BofA 2022 Global Healthcare Conference
Emma Walmsley, CEO, participated in a fireside chat at the BofA Global Healthcare Conference on Friday 16 September at 0815 BST.
07 September 2022
Citi 17th Annual BioPharma Conference
Roger Connor, President Global Vaccines & Global Health and Phil Dormitzer, SVP, Head of Vaccines R&D joined Andrew Baum in a fireside chat at Citi’s 17th Annual BioPharma Conference which took place Wednesday, September 7 at 1:50pm ET/6:50pm UK.
14 June 2022
dbAccess Global Consumer Conference 2022
Tobias Hestler, CFO GSK Consumer Healthcare participated in a fireside chat at the dB Access Global Consumer Conference on 14th June 2022 at 14:45pm BST (15:45pm CEST, 9:45am EDT).
13 June 2022
Goldman Sachs 43rd Annual Global Healthcare Conference
Deborah Waterhouse, CEO, ViiV Healthcare, and Dr. Kimberly Smith, Head of R&D, ViiV Healthcare, discussed progress being made in the HIV space during a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference, Monday, June 13th at 10:00pm UK / 5:00pm ET
24 May 2022
UBS Global Healthcare Conference 2022
Dr. Kimberly Smith, Head of R&D, ViiV Healthcare, discussed progress being made in HIV innovation during a fireside chat at the UBS Global Healthcare Conference on Tuesday, May 24th at 2:15pm UK / 9:15am ET.
20 May 2022
JPMorgan CEO Consumer Staples fireside chat series
Brian McNamara, CEO Designate of Consumer Healthcare, participated in a fireside chat with JPMorgan analyst Celine Pannuti as part of her series of discussions with consumer staples CEOs. In the conversation Brian discussed the growth outlook across various consumer health categories, recent innovation trends and progress towards becoming a standalone company.
05 April 2022
ESG Investor Education Event (Environment)
Claire Lund, Vice President Environmental Sustainability, hosted our first ESG Investor Education Event focusing on our environment strategy, 5 April 2022 at 15:00 BST / 10:00 EDT.
09 March 2022
UBS Global Consumer and Retail Conference 2022
Tobias Hestler, CFO Designate of Consumer Healthcare, participated in a fireside chat at the UBS Global Consumer and Retail Conference hosted by UBS analyst Guillaume Delmas.
07 March 2022
Cowen 42nd Annual Health Care Conference
Hal Barron, Chief Scientific Officer and President R&D, discussed the progress GSK is making in R&D during a fireside chat at the Cowen 42nd Annual Health Care Conference taking place virtually on Monday, 7 March 2022 at 4:10pm UK/11:10pm ET.
28 February 2022
GSK Consumer Healthcare Capital Markets Day
GSK's Consumer Healthcare Capital Markets Day took place on Monday 28 February 2022. This event provided details on our strategy, brands, capabilities and operations, as well as detailed financial information and future growth ambitions ahead of the proposed listing on the London Stock Exchange following the anticipated demerger from GSK mid-2022.
10 February 2022
FCLT Global presents “Investing in Healthcare Innovations: A Case Study of Multi-stakeholder Capitalism in Practice"
Roger Connor, President Global Vaccines & Global Health, particpated in a panel hosted by FCLT Global on Thursday, February 10th at 8:00am ET/1:00pm GMT. The panel focused on navigating the complexity of long-term strategies and investment since financing healthcare advancements, and particularly vaccine development, became central priority with the onset of COVID19.
11 January 2022
JP Morgan Healthcare Conference 2022
Emma Walmsley, Chief Executive Officer, presented at the 40th annual JP Morgan Healthcare Conference on Tuesday 11 January at 07:30-08:10am ET / 12:30-13:10 GMT. The 40 minute session included a presentation and a moderated Q&A discussion.
06 January 2022
Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference
Emma Walmsley, Chief Executive Officer, participated in the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference: A View from the Top, on Thursday, 6 January 2022 at 8:00am ET.
